When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOK - MyoKardia inks lead drug licensing pact with LianBio in China
MyoKardia Inc.
MyoKardia (NASDAQ:MYOK)+1.3% premarket, has announced a license agreement with LianBio, for the development and commercialization of its lead drug candidate, mavacamten for hypertrophic cardiomyopathy (HCM) in China, other Asian territories.
More news on: MyoKardia, Inc., Healthcare stocks news,